Is Enoxaparin Safe for Patients with Renal Failure? Journal Watch. 2004;3(4) Unlike unfractionated heparin (UFH), the low-molecular-weight heparin enoxaparin (Lovenox) is excreted mainly by the ...

A new analysis of the OASIS-5 study has found that it is important to take renal function into account when deciding which antithrombotics to use in patients with acute coronary syndrome.

Correspondence Antithrombotic Prophylaxis and Therapy in Renal Failure. Dtsch Arztebl Int 2011; 108(7): 112-3.DOI: 10.3238/arztebl.2011.0112b ...

(2005) Dosing strategy in patients with renal failure receiving enoxaparin for the treatment of non-ST-segment elevation acute coronary syndrome. Clin Pharmacol Ther 77: 542–552.

The primary outcome occurred in six (5.7%) of the 105 patients with normal kidney function and 13 (22%) of the 59 who had moderate renal impairment, Dr. DeCarolis’s group reported in ...

Enoxaparin is indicated for preventing ... • Use with caution in patients with kidney ... They should NOT be used for the diagnosis or treatment of any health-related condition or disease.

Nine days after treatment, the composite end point of death, MI, or refractory ischemia occurred in 6.7% of fondaparinux recipients and 7.4% of those receiving enoxaparin, a nonsignificant ...

A total of 6528 subjects underwent randomization, 4495 of whom could be evaluated for the primary efficacy outcome — 2211 in the apixaban group and 2284 in the enoxaparin group.

(HealthDay) -- For patients with chronic kidney disease (CKD) who undergo total hip replacement (THR), the rate of major venous thromboembolism (VTE) is significantly higher in those treated with ...

The authors postulate a “deep compartment” for enoxaparin. This is surprising in view of a distribution volume of some 5 liters and monophasic elimination (compare product information).